Birdwatch Note
2025-03-09 06:19:46 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
そもそも「ケタペン」という薬剤は存在しない。 フェンタニルは1972年日本に導入されたが、流通・使用は「麻薬及び向精神薬取締法」で厳格に管理されている。 一方、WHOは疼痛管理のためのオピオイド適正使用量指標を定めているが、日本は約75%と、むしろ充分な使用がされていないことが問題となっている。 日本でのオピオイドクライシスを防ぐために https://www.jstage.jst.go.jp/article/jjspc/28/12/28_21-0059/_article/-char/ja/ Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan https://www.jmaj.jp/detail.php?id=10.31662%2Fjmaj.2020-0037
Written by 002CC6530A91707CBD2863FA9D55197FD120B3CB0E3213F4C4890511FB9E707D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1898303842011287798
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1898619702022389902
- noteId - 1898619702022389902
- participantId -
- noteAuthorParticipantId - 002CC6530A91707CBD2863FA9D55197FD120B3CB0E3213F4C4890511FB9E707D Participant Details
- createdAtMillis - 1741501186267
- tweetId - 1898303842011287798
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- そもそも「ケタペン」という薬剤は存在しない。 フェンタニルは1972年日本に導入されたが、流通・使用は「麻薬及び向精神薬取締法」で厳格に管理されている。 一方、WHOは疼痛管理のためのオピオイド適正使用量指標を定めているが、日本は約75%と、むしろ充分な使用がされていないことが問題となっている。 日本でのオピオイドクライシスを防ぐために https://www.jstage.jst.go.jp/article/jjspc/28/12/28_21-0059/_article/-char/ja/ Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan https://www.jmaj.jp/detail.php?id=10.31662%2Fjmaj.2020-0037
Note Ratings
rated at | rated by | |
2025-03-10 01:09:09 -0500 | Rating Details | |
2025-03-09 23:18:39 -0500 | Rating Details | |
2025-03-09 22:59:01 -0500 | Rating Details | |
2025-03-09 21:00:24 -0500 | Rating Details | |
2025-03-09 20:34:15 -0500 | Rating Details | |
2025-03-09 20:26:04 -0500 | Rating Details | |
2025-03-09 17:42:13 -0500 | Rating Details | |
2025-03-09 13:25:56 -0500 | Rating Details | |
2025-03-09 12:51:45 -0500 | Rating Details | |
2025-03-09 12:46:38 -0500 | Rating Details | |
2025-03-09 12:39:41 -0500 | Rating Details | |
2025-03-09 10:48:18 -0500 | Rating Details | |
2025-03-09 10:32:09 -0500 | Rating Details | |
2025-03-09 09:57:41 -0500 | Rating Details | |
2025-03-09 09:46:40 -0500 | Rating Details | |
2025-03-09 07:37:37 -0500 | Rating Details | |
2025-03-09 07:20:49 -0500 | Rating Details | |
2025-03-09 07:09:23 -0500 | Rating Details | |
2025-03-09 06:37:07 -0500 | Rating Details | |
2025-03-09 06:18:29 -0500 | Rating Details | |
2025-03-09 05:40:36 -0500 | Rating Details | |
2025-03-09 05:40:35 -0500 | Rating Details | |
2025-03-09 05:24:24 -0500 | Rating Details | |
2025-03-09 05:16:16 -0500 | Rating Details | |
2025-03-09 05:13:50 -0500 | Rating Details | |
2025-03-09 04:47:49 -0500 | Rating Details | |
2025-03-09 04:40:30 -0500 | Rating Details | |
2025-03-09 04:36:21 -0500 | Rating Details | |
2025-03-09 04:29:56 -0500 | Rating Details | |
2025-03-09 04:05:04 -0500 | Rating Details | |
2025-03-09 01:52:13 -0600 | Rating Details | |
2025-03-09 01:46:54 -0600 | Rating Details | |
2025-03-09 01:41:20 -0600 | Rating Details | |
2025-03-09 01:41:08 -0600 | Rating Details | |
2025-03-09 01:27:56 -0600 | Rating Details | |
2025-03-09 01:13:21 -0600 | Rating Details | |
2025-03-09 01:09:52 -0600 | Rating Details | |
2025-03-09 01:08:00 -0600 | Rating Details | |
2025-03-09 00:59:06 -0600 | Rating Details | |
2025-03-09 00:51:41 -0600 | Rating Details | |
2025-03-09 00:45:11 -0600 | Rating Details | |
2025-03-09 00:28:43 -0600 | Rating Details | |
2025-03-12 16:54:00 -0500 | Rating Details | |
2025-03-12 13:39:38 -0500 | Rating Details | |
2025-03-11 02:38:25 -0500 | Rating Details | |
2025-03-11 01:12:05 -0500 | Rating Details | |
2025-03-09 21:38:19 -0500 | Rating Details | |
2025-03-09 21:13:30 -0500 | Rating Details | |
2025-03-09 20:39:49 -0500 | Rating Details | |
2025-03-09 20:23:01 -0500 | Rating Details | |
2025-03-09 19:42:43 -0500 | Rating Details | |
2025-03-09 18:42:39 -0500 | Rating Details | |
2025-03-09 17:18:51 -0500 | Rating Details | |
2025-03-09 15:56:24 -0500 | Rating Details | |
2025-03-09 09:42:31 -0500 | Rating Details | |
2025-03-09 08:22:31 -0500 | Rating Details | |
2025-03-09 08:19:27 -0500 | Rating Details | |
2025-03-09 06:51:00 -0500 | Rating Details | |
2025-03-09 06:31:30 -0500 | Rating Details | |
2025-03-09 05:28:07 -0500 | Rating Details | |
2025-03-09 04:55:58 -0500 | Rating Details | |
2025-03-09 04:49:24 -0500 | Rating Details | |
2025-03-09 04:33:46 -0500 | Rating Details | |
2025-03-09 03:36:14 -0500 | Rating Details | |
2025-03-09 01:51:18 -0600 | Rating Details | |
2025-03-09 01:46:22 -0600 | Rating Details | |
2025-03-09 01:21:16 -0600 | Rating Details | |
2025-03-09 01:05:20 -0600 | Rating Details | |
2025-03-09 00:33:05 -0600 | Rating Details | |
2025-03-09 00:25:53 -0600 | Rating Details | |
2025-03-09 00:22:31 -0600 | Rating Details |